Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EU discord over US blood pressure reclassification

This article was originally published in Clinica

Executive Summary

European hypertension experts are voicing their opposition to the recent reclassification of the condition by its US counterparts, with implications for the treatment monitoring market. The American Society of Hypertension (ASH) recommends that blood pressure management be extended to anyone with diastolic/systolic levels of over 120/80mmHg - compared with the widely accepted 140/90mmHg threshold. It also recommends, controversially, that this group be pre-emptively managed using diuretics.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT062405

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel